Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(9%)
Results Posted
17%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
1
9%
Ph phase_3
1
9%
Ph phase_4
1
9%
Ph not_applicable
8
73%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Not yet recruiting1
Recruiting1
Terminated1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (9.1%)
Phase 31 (9.1%)
Phase 41 (9.1%)
N/A8 (72.7%)

Trials by Status

not_yet_recruiting19%
recruiting19%
terminated19%
unknown19%
completed655%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
11